R&D Take the hybrid road to bring clinical trials to patients As the landscape of clinical trials evolves, decentralised clinical trials (DCTs) have emerged to put patients at the centre of the research process.
Views & Analysis How AI-powered adaptive design helped Eisai launch Leqembi At DPHARM 2023 in Boston, Eisai insiders described the Bayesian design of Leqembi's phase 2 trial.
Events Partner Content 10th annual Adaptive Designs in Clinical Trials Adaptive Designs in Clinical Trials 2018
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.